Bullboard - Stock Discussion Forum Cotinga Pharmaceuticals Inc COTQF

Healthcare Biotechnology

Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up... see more

Add To Watchlist

GREY:COTQF - Post Discussion

Cotinga Pharmaceuticals Inc > Not ONE insider buy all year

View:

Post by Spartan8er on Jun 16, 2017 2:59pm

Not ONE insider buy all year

Can someone tell me why the insiders have not bought one share on the OPEN MARKET, but find the need to spend 200,000 dollars plus a month on a PR budget? Using shareholders money quite freely doing that.

https://www.canadianinsider.com/company?menu_tickersearch=COT%20%7C%20Critical%20Outcome

Anyone answer me this............. ANYONE

230

Comment

Comment by DIYGuy on Jun 16, 2017 4:48pm

No one is happy but you can at least state the facts we know. "Also, further to its press release of March 16, 2017, the Company wishes to provide additional information regarding the investor relations engagements of Hybrid Financial Inc. ("Hybrid") and Stern Investor Relations, Inc. ("Stern"). Under the terms of the engagements, COTI expects to pay aggregate fees of ...more

157

Comment

Cotinga Pharmaceuticals Inc